Bivalent COVID-19 Vaccine Recommendation Expands To Include Children Ages 6 Months Through 5 Years  

Last week, following authorization by the U.S. Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC) recommended expanded use of the bivalent COVID-19 vaccine to children ages 6 months through 5 years.